DNA Single Nucleotide Polymorphisms as Predictors of Toxicity

Clinical trial NCT02478476 · UNKNOWN

Trial details

NCT number: NCT02478476
Sponsor: OvaGene Oncology, Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms

Start date: 2015-07-01
Primary completion: 2016-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.